EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CORT: Corcept Therapeutics

06 Aug 26 13:53
LAST:

107.9

CHANGE:
 2.83		OPEN:
110.7		HIGH:
111.0		ASK:
25.5		VOLUME:
201.9K
CHG(%):
2.55		PREV:
110.7		LOW:
107.3		BID:
18.1		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 Aug 26110.7111.0107.3107.9201.9K
05 Aug 26111.0112.0109.2110.7846.8K
04 Aug 26113.0113.5109.0109.81.27M
03 Aug 26114.2115.0109.0112.81.69M
31 Jul 26118.1118.5111.8114.51.84M
30 Jul 26112.0122.2104.8118.34.5M
29 Jul 2694.896.691.593.01.55M
28 Jul 2690.994.390.094.2823.4K
27 Jul 2691.693.490.191.11.42M
24 Jul 2696.897.694.695.41.0M

PROFILE

Name:Corcept Therapeutics
About:Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of hypercortisolism; relacorilant combined with nab-paclitaxel which is in phase III clinical trial to treat platinum-resistant ovarian tumors; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; and for treatment for prostate cancer which is in phase II clinical trial. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; and miricorilant, which is in phase IIb trial for the treatment of metabolic dysfunction-associated steatohepatitis. The company was incorporated in 1998 and is headquartered in Redwood City, California.
Sector:Healthcare
Industry:Biotechnology
Address:101 Redwood Shores Parkway, Redwood City, CA, United States, 94065
Website:https://www.corcept.com
CUSIP:218352102
CIK:0001088856
ISIN:US2183521028
FIGI:BBG000BKJG33
LEI:529900EO9LUTFMZ7FF90

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:261.74 
Forward P/E:36.72 
Price to Sales:12.97 
Price to Book:15.41 
EPS Ratio:0.35 
Revenue:716.08M 
EBITDA:102.62M 
Shares:107.35M 
Market Cap:11.579B 

TECHNICAL INDICATORS

MA5:111.133.0%
MA10:104.763.0%
MA20:98.0210.0%
MA50:87.7822.9%
MA100:66.8561.4%
MA200:62.4872.7%
STO9:53.86
STO14:54.21
RSI14:63.74 
WPR14:-38.10
MTM14:16.30
ROC14:0.18 
ATR:6.37 
Week High:122.2113.3%
Week Low:104.753.0%
Month High:122.2113.3%
Month Low:84.8872.7%
Year High:122.2113.3%
Year Low:28.66276.4%